Skip to content

Endoscopic Dacryocystorhinostomy as Primary versus Secondary Treatment in Acute Dacryocystitis

Endoscopic Dacryocystorhinostomy as Primary versus Secondary Treatment in Acute Dacryocystitis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003191
Enrollment
Unknown
Registered
2013-04-28
Start date
2013-02-14
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Dacryocystitis

Interventions

two groups:Control group: EN-DCR will be performed within 1 month after acute dacryocystitis subsides with initial percutaneous drainage, as a secondary treatment of the underlying nasolacrimal duct o

Sponsors

Hong Kong Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Subjects with acute dacryocystitis, defined as painful lacrimal sac distention with marked medial canthal inflammation of less than 2 weeks; 2. Age 18-90; 3. Fit for operation under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. History of DCR; 2. History of trauma / neoplasm / congenital anomalies of lacrimal drainage system; 3. History maxillofacial surgery or trauma; 4. Immunocompromized patients; 5. Poor cooperation for operation or subsequent endoscopic examination; 6. Fail or refuse to give consent.

Design outcomes

Primary

MeasureTime frame
Resolution of symptoms of acute dacryocystitis including pain;medial canthal swelling;epiphora;discharge;associated cellulitis and fever;

Secondary

MeasureTime frame
1. Efficacy of EN-DCR -Anatomical success -Functional success;2. Safety of EN-DCR - incidence of complications;3. Causative agents of acute dacryocystitis in Hong Kong;

Countries

China

Contacts

Public ContactLi Yuen Mei, Emmy
emmyli@gmail.com+852 27623000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026